Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets (2025)

ZHEJIANG SHOUXIANGU PHARMACEUTICAL CO., LTD.

Add to a list

To use this feature you must be a member

Log inSign up

Equities

603896

CNE100002XJ4

Pharmaceuticals
End-of-day quote Shanghai S.E.

Other stock markets

21/03/2025
5-day change 1st Jan Change
20.89 CNY +0.10% Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets (2) -1.65% -1.51%
03-19 Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets MT
11-07 Shouxiangu Pharmaceutical's Unit Gets Registration Certificate for Food Supplement; Shares Up 4% MT

March 19, 2025 at 06:51 am

Share

Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets (3)This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Share

Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets (4)

© MT Newswires - 2025

Latest news about Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets 03-19 MT
Shouxiangu Pharmaceutical's Unit Gets Registration Certificate for Food Supplement; Shares Up 4% 11-07 MT
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 28/10/24 CI
Zhejiang Shouxiangu Pharmaceutical Subsidiary Gets 350-Million-Yuan Construction Contract 30/09/24 MT
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 27/08/24 CI
Shouxiangu Pharmaceutical Gets Patent for Chinese Medicine Composition 12/07/24 MT
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 24/04/24 CI
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 26/10/23 CI
18/09/23 CI
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. agreed to acquire Hangzhou Yunhe Hengli Commercial Real Estate Co., Ltd from Hangzhou Yunhe Group Construction Management Co., Ltd. for CNY 0.001 million. 12/09/23 CI
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 26/07/23 CI
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 27/04/23 CI
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 03/03/23 CI
Shouxiangu Pharma Unit Secures Re-Registration Approval for Three Drugs 17/01/23 MT
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 26/10/22 CI
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 21/07/22 CI
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 28/04/22 CI
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 27/01/22 CI
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021 27/10/21 CI
Tranche Update on Zhejiang Shouxiangu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 4, 2020. 12/10/21 CI
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.'s Equity Buyback announced on November 4, 2020, has expired with 3,585,000 shares, representing 2.5% for CNY 165.08 million. 10/10/21 CI
Tranche Update on Zhejiang Shouxiangu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 4, 2020. 07/10/21 CI
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021 24/08/21 CI
Tranche Update on Zhejiang Shouxiangu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on November 4, 2020. 01/07/21 CI
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 28/04/21 CI

Chart Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets (5)

603896: Dynamic Chart

Company Profile

Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets (6)

Zhejiang Shouxiangu Pharmaceutical Co Ltd is a China-based company principally engaged in the breeding, cultivation, processing and sales of traditional Chinese medicinal materials, such as the ganoderma lucidums and dendrobium officinales. The Company's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The Company mainly operates its businesses in domestic markets through wholesaling and direct sales.

Employees

1,143

Sector

Pharmaceuticals

Calendar

04-17 - Q4 2024 Earnings Release

More about the company

Income Statement and Estimates

Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets (7)

More financial data

Analysts' Consensus

Sell

Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets (8)

Buy

Mean consensus

OUTPERFORM

Number of Analysts

2

Last Close Price

20.89CNY

Average target price

31.40CNY

Spread / Average Target

+50.31%

Consensus

Profit revisions

Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets (9)

Estimate revisions

Annual profits - Rate of surprise

Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets (10)

Company calendar

  1. Stock Market
  2. Equities
  3. 603896 Stock
  4. News Zhejiang Shouxiangu Pharmaceutical Co., Ltd.
  5. Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets
Extended Sales | 40% Discount : The Best Subscriber-Only Tools to Identify Tomorrow's Best Investments! d : : BENEFIT NOW
"); for (var element in ICConf) { if (document.getElementById("zpp"+element)) { document.getElementById("zpp"+element).innerHTML = ""; } } InvestingChannelQueue.push(function() { ic_page = InvestingChannel.UAT.Run("5c5a75c3-8896-4592-98f8-dc06e6fdcc56"); }); } $(document).ready(function() {gaEvent('adspv', 'InvestingChannel_v2', 'US');});googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_GB');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '42613224');googletag.enableServices();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });
Zhejiang Shouxiangu Pharmaceutical Completes Domestic Health Food Filing for Spore Powder Tablets (2025)

References

Top Articles
Latest Posts
Recommended Articles
Article information

Author: Kerri Lueilwitz

Last Updated:

Views: 6286

Rating: 4.7 / 5 (47 voted)

Reviews: 86% of readers found this page helpful

Author information

Name: Kerri Lueilwitz

Birthday: 1992-10-31

Address: Suite 878 3699 Chantelle Roads, Colebury, NC 68599

Phone: +6111989609516

Job: Chief Farming Manager

Hobby: Mycology, Stone skipping, Dowsing, Whittling, Taxidermy, Sand art, Roller skating

Introduction: My name is Kerri Lueilwitz, I am a courageous, gentle, quaint, thankful, outstanding, brave, vast person who loves writing and wants to share my knowledge and understanding with you.